Cincinnati, Ohio 45219

  • Hemorrhage

Purpose:

This study will evaluate the accuracy of two rapid methods of measuring hemoglobin in patients with suspected hemorrhage. These methods will be compared with standard laboratory measurements.


Study summary:

Anemia and bleeding are major causes of morbidity and mortality in both surgical and nonsurgical patients. The current standard of care for monitoring patients at risk for bleeding is serial measurement of hemoglobin levels. At present, the photometric cyanmethemoglobin method is the most widely used technique for monitoring hemoglobin in the lab, and is currently the gold standard. However, this method has potential for delay before final results are obtained. Immediate hemoglobin measurements are available with portable point-of-care devices such as the iSTAT, which can produce a measurement of hemoglobin concentration in less than 1 minute. Unfortunately, the accuracy of this device has been reported to vary with hemoglobin level, and as such may not be as accurate in detecting blood loss when compared with the gold standard of laboratory analysis. Recently, a noninvasive, spectrophotometry-based monitoring technology has been developed. This novel technology measures the differential optical density of wavelengths of light passed through the finger in a method similar to conventional pulse oximetry. While some studies have reported that this device appears to be accurate in patients undergoing elective surgical procedures, more recent work suggests that this accuracy degrades with increased blood loss, lower oximeter signal quality and lower absolute Hgb values. We will evaluate the accuracy of point-of-care and non-invasive SpHb measurements and utility of continuous hemoglobin monitoring in an intensive care unit setting. If these methods of rapid hemoglobin measurement can be validated in patients at risk for ongoing hemorrhage, use of this technology may result in earlier detection of ongoing hemorrhage, expedite appropriate treatment, and improve patient outcomes.


Criteria:

Inclusion Criteria: - admitted to surgical intensive care unit (SICU), and - at risk of ongoing bleeding, and - requires serial CBC measurements Exclusion Criteria: - < 18 years of age, or - a prisoner, or - unable to have pulse oximetry readings (due to injuries, burns, amputations, or related problems)


NCT ID:

NCT01709786


Primary Contact:

Betty J Tsuei, MD
Phone: 513-558-5661
Email: betty.tsuei@uc.edu


Backup Contact:

Email: richard.branson@uc.edu
Richard D Branson, MSc
Phone: 513-558-6785


Location Contact:

Cincinnati, Ohio 45219
United States

Betty J Tsuei, MD
Phone: 513-558-5661
Email: betty.tsuei@uc.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.